Search intent hub
Recovery Peptides
A sober look at BPC-157, TB-500, and wound-healing claims without injury-cure hype.
Concise answer
What searchers should know
Popular recovery peptides are mostly supported by animal or mechanistic research, not strong human clinical trials.
Guide note
The evidence problem
Animal healing models are useful for generating hypotheses, but they do not prove human recovery benefits.
Guide note
The regulatory problem
Several recovery peptides are not FDA-approved for human use and may raise compounding, product-quality, and anti-doping issues.
Guide note
The practical bottom line
Injuries need diagnosis, rehabilitation planning, and clinician oversight. PeptideWars does not provide recovery protocols.
Profiles
Peptides in This Hub
BPC-157
A synthetic 15-amino-acid research peptide with extensive animal data and very limited human evidence.
TB-500
A synthetic fragment associated with thymosin beta-4 biology, with evidence often extrapolated from the parent molecule.
GHK-Cu
A copper-binding tripeptide discussed in skin biology, cosmetic formulations, and wound-healing research.
Battles
Related Comparisons
Common Questions
Which recovery peptide has the best evidence?
None of the common research-only recovery peptides has strong enough human evidence to be called proven.
Are BPC-157 and TB-500 allowed in sport?
BPC-157 is specifically flagged by USADA. Athletes should check official anti-doping rules before using any peptide.